Source: Vadym.

Equities in Canada’s largest market kept steady on Thursday, as commodities-linked sectors found support from a surprise domestic trade surplus in August. Statistics Canada reported that in August, the country’s merchandise trade balance went from a deficit to a surplus as exports increased 5.7 per cent, while imports rose 3.8 per cent.

U.S. stock futures dipped into the red, as Wall Street struggled to maintain the positive momentum from the previous session. The major averages are on pace for another losing week, but yields climbed down from 16-year highs. Weekly initial jobless claims came in at 207,000 for the week ending Sept. 30, up 2,000 from week before.

TSX19,137.81+103.00TSX
TSXV527.90-5.28TSXV
CSE173.95-1.47TSXV
DJIA33,119.57-9.98DJIA
NASDAQ13,219.83-16.18NASDAQ
S&P 5004,259.68-4.07S&P 500

The Canadian dollar traded for 72.90 cents U.S., compared to 72.77 cents U.S. on Wednesday.

U.S. crude futures traded $1.84 lower at $82.38 a barrel, and the Brent contract lost $1.65 to $84.16 a barrel.

The price of gold was down US$2.70 to US$1,820.27.

In world markets, the Nikkei was up 548.48 points to 31,075.36, the Hang Seng was up 18.03 points to 17,213.87, the FTSE was up 39.09 points to 7,451.54, and the DAX was down 29.70 points to 15,070.22.


The material provided in this article is for information only and should not be treated as investment advice. For full disclaimer information, please click here.


More From The Market Online

ESE producing championship e-sports tournament for Riot Games

ESE Entertainment’s (TSXV:ESE) media production unit, Frenzy, takes on the distribution of the upcoming Teamfight Tactics e-sports tournament.

York Harbour Metals reveals more promising rare earth sampling assays

York Harbour Metals (TSXV:YORK) reports encouraging findings in its latest Bottom Brook Rare Earth Elements project analysis.

Optimi Health makes first international MDMA shipment

Optimi Health (CSE:OPTI) makes its first international shipment of MDMA to The Institute for Psychedelic Research at Tel Aviv University.

Oncolytics Biotech approved to expand pancreatic cancer program

Oncolytics Biotech (TSX:ONC), a cancer immunotherapy stock, receives ethics and German regulatory approvals for a new pancreatic cancer study.